{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:14:53Z","timestamp":1789352093037,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"DOI":"10.1097\/qai.0b013e31817ae5c0","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T13:39:52Z","timestamp":1236260392000},"page":"324-333","source":"Crossref","is-referenced-by-count":38,"title":["Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study"],"prefix":"10.1097","volume":"48","author":[{"given":"Wendy P","family":"Bannister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Mocroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor von","family":"Wyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Lazzarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/135965350000500112","article-title":"The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.","volume":"5","author":"De Gruttola","year":"2000","journal-title":"Antivir Ther"},{"key":"R2-13-20210131","first-page":"670","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.","volume":"271","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"R3-13-20210131","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.279.24.2000","article-title":"Drug-resistant HIV-1: the virus strikes back.","volume":"279","author":"Mayers","year":"1998","journal-title":"JAMA"},{"key":"R4-13-20210131","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","article-title":"The prevalence of antiretroviral drug resistance in the United States.","volume":"18","author":"Richman","year":"2004","journal-title":"AIDS"},{"key":"R5-13-20210131","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.279.24.1977","article-title":"Public health implications of antiretroviral therapy and HIV drug resistance.","volume":"279","author":"Wainberg","year":"1998","journal-title":"JAMA"},{"key":"R6-13-20210131","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(98)12262-6","article-title":"Transmission of antiretroviral-drug-resistant HIV-1 variants.","volume":"354","author":"Yerly","year":"1999","journal-title":"Lancet"},{"key":"R7-13-20210131","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/519173","article-title":"Transmitted HIV-1 drug resistance: are we seeing just the tip of an epidemiological iceberg?","volume":"196","author":"Stekler","year":"2007","journal-title":"J Infect Dis"},{"key":"R8-13-20210131","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/135965350400900619","article-title":"Updated European recommendations for the clinical use of HIV drug resistance testing.","volume":"9","author":"Vandamme","year":"2004","journal-title":"Antivir Ther"},{"key":"R9-13-20210131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/375597","article-title":"Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.","volume":"37","author":"Hirsch","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R10-13-20210131","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.","volume":"192","author":"Wensing","year":"2005","journal-title":"J Infect Dis"},{"key":"R11-13-20210131","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/00365540310016916","article-title":"Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.","volume":"35","author":"Jorgensen","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"R12-13-20210131","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s15010-002-3055-4","article-title":"High prevalence of genotypic resistance to nucleoside reverse transcriptase inhibitors among therapy-naive individuals from the Warsaw cohort.","volume":"30","author":"Horban","year":"2002","journal-title":"Infection"},{"key":"R13-13-20210131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virusres.2005.03.004","article-title":"Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.","volume":"112","author":"Paraskevis","year":"2005","journal-title":"Virus Res"},{"key":"R14-13-20210131","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2004.00938.x","article-title":"Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naive for anti-retrovirals.","volume":"10","author":"Torti","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"R15-13-20210131","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1097\/00126334-200412150-00022","article-title":"Current levels of drug resistance among therapy-naive HIV infected patients have significant impact on treatment response.","volume":"37","author":"Derdelinckx","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-13-20210131","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/135965350400900505","article-title":"Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems.","volume":"9","author":"De Luca","year":"2004","journal-title":"Antivir Ther"},{"key":"R17-13-20210131","first-page":"273","article-title":"Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany.","volume":"9","author":"Oette","year":"2004","journal-title":"Eur J Med Res"},{"key":"R18-13-20210131","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/135965350400900312","article-title":"Infrequent transmission of HIV-1 drug-resistant variants.","volume":"9","author":"Yerly","year":"2004","journal-title":"Antivir Ther"},{"key":"R19-13-20210131","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/00002030-200312050-00011","article-title":"Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.","volume":"17","author":"Chaix","year":"2003","journal-title":"AIDS"},{"key":"R20-13-20210131","first-page":"451","article-title":"Fast genotypic detection of drug resistance mutations in the HIV-1 reverse transcriptase gene of treatment-naive patients.","volume":"1","author":"Fontaine","year":"1998","journal-title":"J Hum Virol"},{"key":"R21-13-20210131","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.qai.0000155201.51232.2e","article-title":"French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.","volume":"38","author":"Descamps","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-13-20210131","first-page":"S137","article-title":"Surveillance of drug resistance and HIV subtypes in newly diagnosed patients in Spain during 2004.","volume":"10","author":"Martinez-Picado","year":"2005","journal-title":"Antivir Ther"},{"key":"R23-13-20210131","first-page":"S126","article-title":"Prevalence of drug-resistance HIV-1 variants in untreated individuals in Europe: implications for clinical management.","volume":"10","author":"van de Vijver","year":"2005","journal-title":"Antivir Ther"},{"key":"R24-13-20210131","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00002030-200203290-00017","article-title":"Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.","volume":"16","author":"Harzic","year":"2002","journal-title":"AIDS"},{"key":"R25-13-20210131","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1468-1293.2006.00412.x","article-title":"Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy.","volume":"7","author":"Fox","year":"2006","journal-title":"HIV Med"},{"key":"R26-13-20210131","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.38665.534595.55","article-title":"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study.","volume":"331","author":"Cane","year":"2005","journal-title":"BMJ"},{"key":"R27-13-20210131","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jac\/dkl501","article-title":"Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection.","volume":"59","author":"Booth","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R28-13-20210131","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.qai.0000219290.49152.6a","article-title":"Tracking the prevalence of transmitted antiretroviral drug resistant HIV-1.","volume":"41","author":"Shet","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-13-20210131","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1086\/427212","article-title":"Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.","volume":"40","author":"Novak","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R30-13-20210131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.qai.0000186361.42834.61","article-title":"Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms.","volume":"40","author":"Masquelier","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-13-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.288.2.181","article-title":"Time trends in primary HIV-1 drug resistance among recently infected persons.","volume":"288","author":"Grant","year":"2002","journal-title":"JAMA"},{"key":"R32-13-20210131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV.","volume":"347","author":"Little","year":"2002","journal-title":"N Engl J Med"},{"key":"R33-13-20210131","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1177\/135965350701200814","article-title":"Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network.","volume":"12","author":"Chaix","year":"2007","journal-title":"Antivir Ther"},{"key":"R34-13-20210131","first-page":"21","article-title":"Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.","volume":"20","author":"de Mendoza","year":"2002","journal-title":"AIDS"},{"key":"R35-13-20210131","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/QAD.0b013e3280b07761","article-title":"Resistance, UK Collaborative HIV Cohort Study, UK Register of HIV Seroconverters. Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom.","volume":"21","year":"2007","journal-title":"AIDS"},{"key":"R36-13-20210131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.qai.0000196666.16616.fe","article-title":"A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections.","volume":"42","author":"Jayaraman","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R38-13-20210131","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study.","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"R39-13-20210131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","article-title":"HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.","volume":"21","author":"Shafer","year":"2007","journal-title":"AIDS"},{"key":"R40-13-20210131","first-page":"119","article-title":"Update of the drug resistance mutations in HIV-1: 2007.","volume":"15","author":"Johnson","year":"2007","journal-title":"Top HIV Med"},{"key":"R43-13-20210131","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jac\/dkm082","article-title":"Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.","volume":"59","author":"Booth","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R44-13-20210131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1386-6532(02)00114-2","article-title":"Rates of transmission of antiretroviral drug resistant strains of HIV-1.","volume":"26","author":"Ammaranond","year":"2002","journal-title":"J Clin Virol"},{"key":"R45-13-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<181::AID-JMV2>3.0.CO;2-T","article-title":"Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection.","volume":"61","author":"Tamalet","year":"2000","journal-title":"J Med Virol"},{"key":"R46-13-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.aids.0000196172.35056.b7","article-title":"The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.","volume":"20","author":"Pillay","year":"2006","journal-title":"AIDS"},{"key":"R47-13-20210131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.qai.0000174652.40782.4e","article-title":"Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure.","volume":"41","author":"Gange","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R49-13-20210131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/47.4.371","article-title":"Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies.","volume":"47","author":"Sabin","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"R50-13-20210131","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00002030-200405210-00008","article-title":"The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution.","volume":"18","author":"Lambotte","year":"2004","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-200807010-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:45:58Z","timestamp":1786038358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200807010-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31817ae5c0","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7,1]]}}}